MXCTNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
MAXCYTE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.30+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $138.87M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
61.3%
63M of 103M shares
Institutional holders
123
27 new, 33 sold out
Net institutional buying
-2M
In Q2 2026
Insider trades, 12 months
0 buys · 1 sales
Net sold $8.32K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Capricorn Fund Managers Ltd | 8,200,000 | 7.70% | 13G (passive) | Jan 30, 2026 |
| Liontrust Investment Partners LLP | 5,194,322 | 5.00% | 13D (active) | Oct 14, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MXCT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Capricorn Fund Managers Ltd | 8,200,000 | 7.95% | $10.09M | – | 0.79% |
| Vitruvian Partners LLP | 5,043,356 | 4.89% | $6.20M | – | 3.09% |
| Vanguard Capital Management LLC | 4,031,284 | 3.91% | $4.96M | +49,468 | 0.00% |
| Morgan Stanley | 3,694,049 | 3.58% | $4.54M | +5,918 | 0.00% |
| Mudita Advisors LLP | 3,370,689 | 3.27% | $4.15M | – | 0.86% |
| BlackRock, Inc. | 3,060,960 | 2.97% | $3.76M | −5,737,513 | 0.00% |
| Brooklands Fund Management Ltd | 2,848,083 | 2.76% | $3.67M | +658,063 | 2.87% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2,773,554 | 2.69% | $3.41M | – | 0.00% |
| Cadian Capital Management, LP | 2,201,166 | 2.13% | $2.71M | +478,224 | 0.20% |
| Peapod Lane Capital LLC | 2,125,752 | 2.06% | $2.61M | +793,559 | 1.76% |
| Renaissance Technologies LLC | 1,910,800 | 1.85% | $2.35M | −82,400 | 0.00% |
| Aqr Capital Management LLC | 1,882,776 | 1.82% | $2.32M | +661,594 | 0.00% |
| Jane Street Group, LLC | 1,563,003 | 1.51% | $1.92M | +1,542,434 | 0.00% |
| Two Sigma Investments, LP | 1,462,941 | 1.42% | $1.80M | +854,779 | 0.00% |
| Geode Capital Management, LLC | 1,326,914 | 1.29% | $1.63M | −1,035,758 | 0.00% |
| RBF Capital, LLC | 1,322,443 | 1.28% | $1.63M | New | 0.07% |
| Goldman Sachs Group Inc | 1,241,943 | 1.20% | $1.53M | +82,924 | 0.00% |
| Millennium Management LLC | 1,204,921 | 1.17% | $1.48M | +1,161,862 | 0.00% |
| Nano Cap New Millennium Growth Fund L P | 1,200,000 | 1.16% | $1.48M | +200,000 | 1.14% |
| Marshall Wace, Llp | 1,014,778 | 0.98% | $1.25M | +915,866 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 123 | 63M | 61.3% | 27 / 51 | 28 / 33 | 13M | 15M |
| Q1 2026 | 131 | 65M | 63.4% | 39 / 30 | 36 / 19 | 25M | 18M |
| Q4 2025 | 112 | 64M | 61.8% | 20 / 28 | 37 / 16 | 8M | 12M |
| Q3 2025 | 112 | 70M | 68.0% | 17 / 33 | 40 / 24 | 10M | 11M |
| Q2 2025 | 120 | 71M | 69.2% | 21 / 43 | 37 / 15 | 7M | 10M |
| Q1 2025 | 114 | 75M | 72.3% | 12 / 41 | 42 / 14 | 12M | 4M |
| Q4 2024 | 119 | 73M | 70.3% | 21 / 45 | 30 / 21 | 10M | 6M |
| Q3 2024 | 120 | 69M | 66.8% | 13 / 50 | 30 / 6 | 12M | 4M |
| Q2 2024 | 114 | 69M | 66.4% | 9 / 49 | 39 / 17 | 5M | 11M |
| Q1 2024 | 123 | 74M | 71.8% | 15 / 42 | 46 / 12 | 10M | 6M |
| Q4 2023 | 120 | 71M | 68.4% | 20 / 50 | 29 / 20 | 21M | 15M |
| Q3 2023 | 120 | 64M | 62.4% | 17 / 42 | 39 / 12 | 5M | 7M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of MXCT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2,742,125 | 2.66% | $3.37M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,161,395 | 1.13% | $1.43M | 0.00% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 518,559 | 0.50% | $627.46K | 0.00% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 394,028 | 0.38% | $476.77K | 0.00% | May 31, 2026 |
| Inception Portfolio | 347,433 | 0.34% | $427.34K | 0.15% | Jun 30, 2026 |
| Vanguard Health Care Index Fund | 301,966 | 0.29% | $365.38K | 0.00% | May 31, 2026 |
| EQ/Morgan Stanley Small Cap Growth Portfolio | 211,975 | 0.21% | $260.73K | 0.05% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 199,501 | 0.19% | $241.40K | 0.00% | May 31, 2026 |
| iShares Core S&P Total U.S. Stock Market ETF | 164,501 | 0.16% | $202.34K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 156,238 | 0.15% | $189.05K | 0.00% | May 31, 2026 |
| Multi-Manager Small Cap Equity Strategies Fund | 144,027 | 0.14% | $174.27K | 0.01% | May 31, 2026 |
| Schwab Total Stock Market Index Fund | 114,828 | 0.11% | $120.57K | 0.00% | Jul 31, 2026 |
| Large-Cap Growth Portfolio | 109,790 | 0.11% | $135.04K | 0.01% | Jun 30, 2026 |
| Goldman Sachs Absolute Return Tracker Fund | 109,491 | 0.11% | $134.67K | 0.00% | Jun 30, 2026 |
| Invesco NASDAQ Future Gen 200 ETF | 94,709 | 0.09% | $114.60K | 0.61% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Maher Masoud | President and CEO, Director | 475,000 | 0.46% | Mar 31, 2026 |
| Parmeet Ahuja | Chief Financial Officer | 187,500 | 0.18% | Apr 17, 2026 |
| Douglas J. Swirsky | CHIEF FINANCIAL OFFICER | 151,669 | 0.15% | Mar 19, 2026 |
| Ali Soleymannezhad | Chief Commercial Officer | 59,439 | 0.06% | Mar 20, 2025 |
| David I. Sandoval | GENERAL COUNSEL | 64,219 | 0.06% | Mar 20, 2025 |
| Rekha Hemrajani | Director | 70,314 | 0.07% | Jun 22, 2026 |
| Patrick J. Balthrop | Director | 80,998 | 0.08% | Jun 22, 2026 |
| John Joseph Johnston | Director | 201,581 | 0.20% | Jun 22, 2026 |
| Richard Douglas | Director | 260,998 | 0.25% | Jun 22, 2026 |
| Yasir B. Al-Wakeel | Director | 80,998 | 0.08% | Jun 22, 2026 |
| William W. Brooke | Director | 181,300 | 0.18% | Jun 22, 2026 |
| Stanley C. Erck | Director | 428,749 | 0.42% | Jun 22, 2026 |
| Cynthia Collins | Director | 111,310 | 0.11% | Jun 22, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Richard Douglas Director | Jun 17, 2026 | Award | +30,421 | – | – | 260,998 |
| William W. Brooke Director | Jun 17, 2026 | Award | +30,421 | – | – | 181,300 |
| Yasir B. Al-Wakeel Director | Jun 17, 2026 | Award | +30,421 | – | – | 80,998 |
| Rekha Hemrajani Director | Jun 17, 2026 | Award | +30,421 | – | – | 70,314 |
| Patrick J. Balthrop Director | Jun 17, 2026 | Award | +30,421 | – | – | 80,998 |
| Cynthia Collins Director | Jun 17, 2026 | Award | +30,421 | – | – | 111,310 |
| Stanley C. Erck Director | Jun 17, 2026 | Award | +30,421 | – | – | 428,749 |
| John Joseph Johnston Director | Jun 17, 2026 | Award | +30,421 | – | – | 201,581 |
| Parmeet Ahuja Chief Financial Officer | Apr 15, 2026 | Award | +187,500 | – | – | 187,500 |
| Maher Masoud President and CEO, Director | Mar 27, 2026 | Award | +300,000 | – | – | 475,000 |
| Douglas J. Swirsky CHIEF FINANCIAL OFFICER | Mar 17, 2026 | Sale | −10,142 | $0.82 | $8.32K | 151,669 |
| Stanley C. Erck Director | Aug 13, 2025 | Buy | +100,000 | $1.37 | $137.00K | 398,328 |
| Richard Douglas Director | Aug 13, 2025 | Buy | +80,000 | $1.39 | $111.20K | 230,577 |
| William W. Brooke Director | Aug 13, 2025 | Buy | +50,000 | $1.29 | $64.50K | 150,879 |
| Maher Masoud President and CEO, Director | Aug 13, 2025 | Buy | +75,000 | $1.37 | $102.75K | 175,000 |
| Douglas J. Swirsky CHIEF FINANCIAL OFFICER | Aug 13, 2025 | Buy | +50,000 | $1.29 | $64.50K | 161,811 |
| Rekha Hemrajani Director | Jun 25, 2025 | Sale(10b5-1 plan) | −10,684 | $2.09 | $22.33K | 39,893 |
| Rekha Hemrajani Director | Jun 18, 2025 | Award | +29,210 | – | – | 50,577 |
| Yasir B. Al-Wakeel Director | Jun 18, 2025 | Award | +29,210 | – | – | 50,577 |
| Patrick J. Balthrop Director | Jun 18, 2025 | Award | +29,210 | – | – | 50,577 |
| Richard Douglas Director | Jun 18, 2025 | Award | +29,210 | – | – | 150,577 |
| Cynthia Collins Director | Jun 18, 2025 | Award | +29,210 | – | – | 80,889 |
| William W. Brooke Director | Jun 18, 2025 | Award | +29,210 | – | – | 100,879 |
| John Joseph Johnston Director | Jun 18, 2025 | Award | +29,210 | – | – | 171,160 |
| Stanley C. Erck Director | Jun 18, 2025 | Award | +29,210 | – | – | 298,328 |
| David I. Sandoval GENERAL COUNSEL | Mar 18, 2025 | Sale | −353 | $3.18 | $1.12K | 64,219 |
| Ali Soleymannezhad Chief Commercial Officer | Mar 18, 2025 | Sale | −1,211 | $3.18 | $3.85K | 59,439 |
| Douglas J. Swirsky CHIEF FINANCIAL OFFICER | Mar 18, 2025 | Sale | −6,939 | $3.18 | $22.07K | 111,811 |
| Douglas J. Swirsky CHIEF FINANCIAL OFFICER | Mar 14, 2025 | Award | +37,500 | – | – | 118,750 |
| Ali Soleymannezhad Chief Commercial Officer | Mar 14, 2025 | Award | +34,625 | – | – | 60,650 |
| David I. Sandoval GENERAL COUNSEL | Mar 14, 2025 | Award | +23,125 | – | – | 64,572 |
| John Joseph Johnston Director | Jan 27, 2025 | Option exercise | +3,000 | $2.93 | $8.79K | 144,950 |
| John Joseph Johnston Director | Jan 27, 2025 | Sale(10b5-1 plan) | −3,000 | $4.65 | $13.95K | 141,950 |
| David I. Sandoval GENERAL COUNSEL | Jan 13, 2025 | Sale | −4,466 | $4.54 | $20.28K | 41,447 |
| John Joseph Johnston Director | Dec 26, 2024 | Sale(10b5-1 plan) | −3,000 | $4.01 | $12.03K | 141,950 |
| John Joseph Johnston Director | Dec 26, 2024 | Option exercise | +3,000 | $2.93 | $8.79K | 144,950 |
| John Joseph Johnston Director | Dec 9, 2024 | Option exercise | +891 | $2.93 | $2.61K | 142,841 |
| John Joseph Johnston Director | Dec 9, 2024 | Option exercise | +1,121 | $1.64 | $1.84K | 143,962 |
| John Joseph Johnston Director | Dec 9, 2024 | Option exercise | +483 | $2.93 | $1.42K | 144,445 |
| John Joseph Johnston Director | Dec 9, 2024 | Sale(10b5-1 plan) | −2,495 | $3.79 | $9.46K | 141,950 |
| John Joseph Johnston Director | Dec 6, 2024 | Sale(10b5-1 plan) | −505 | $3.70 | $1.87K | 141,950 |
| John Joseph Johnston Director | Dec 6, 2024 | Option exercise | +505 | $2.93 | $1.48K | 142,455 |
| Stanley C. Erck Director | Nov 1, 2024 | Sale(10b5-1 plan) | −47,689 | $3.72 | $177.40K | 269,118 |
| Stanley C. Erck Director | Nov 1, 2024 | Option exercise | +47,689 | $0.04 | $1.91K | 316,807 |
| John Joseph Johnston Director | Oct 28, 2024 | Option exercise | +3,000 | $2.93 | $8.79K | 144,950 |
| John Joseph Johnston Director | Oct 28, 2024 | Sale(10b5-1 plan) | −3,000 | $3.72 | $11.16K | 141,950 |
| Cynthia Collins Director | Oct 14, 2024 | Award | +51,679 | – | – | 51,679 |
| Stanley C. Erck Director | Oct 2, 2024 | Sale(10b5-1 plan) | −21,607 | $3.71 | $80.16K | 269,118 |
| Stanley C. Erck Director | Oct 2, 2024 | Option exercise | +21,607 | $0.04 | $864 | 290,725 |
| Stanley C. Erck Director | Oct 1, 2024 | Option exercise | +26,082 | $0.04 | $1.04K | 295,200 |
| Stanley C. Erck Director | Oct 1, 2024 | Sale(10b5-1 plan) | −26,082 | $3.78 | $98.59K | 269,118 |
| John Joseph Johnston Director | Sep 26, 2024 | Option exercise | +3,000 | $2.93 | $8.79K | 144,950 |
| John Joseph Johnston Director | Sep 26, 2024 | Sale(10b5-1 plan) | −3,000 | $3.82 | $11.46K | 141,950 |
| Ali Soleymannezhad Chief Commercial Officer | Sep 16, 2024 | Award | +10,400 | – | – | 26,025 |
| Stanley C. Erck Director | Sep 4, 2024 | Sale(10b5-1 plan) | −29,767 | $3.97 | $118.17K | 269,118 |
| Stanley C. Erck Director | Sep 4, 2024 | Option exercise | +29,767 | $0.04 | $1.19K | 298,885 |
| Stanley C. Erck Director | Sep 3, 2024 | Sale(10b5-1 plan) | −17,922 | $4.10 | $73.48K | 269,118 |
| Stanley C. Erck Director | Sep 3, 2024 | Option exercise | +17,922 | $0.04 | $717 | 287,040 |
| John Joseph Johnston Director | Aug 26, 2024 | Sale(10b5-1 plan) | −3,000 | $4.28 | $12.84K | 141,950 |
| John Joseph Johnston Director | Aug 26, 2024 | Option exercise | +3,000 | $2.93 | $8.79K | 144,950 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Rekha Hemrajani Director | Jun 25, 2025 | 10,684 | $22.38K | Jun 25, 2025 | Restricted Stock Units |
| John Joseph Johnston Affiliate | Dec 26, 2024 | 12,000 | $49.32K | Dec 26, 2024 | option exercise |
| John Joseph Johnston Affiliate | Sep 26, 2024 | 9,000 | $34.29K | Sep 26, 2024 | option exercise |
| Stanley C. Erck Officer | Sep 3, 2024 | 143,067 | $618.05K | Sep 3, 2024 | Option Exercise |
| John Joseph Johnston Affiliate | Jun 27, 2024 | 16,000 | $63.68K | Jun 27, 2024 | option exercise |
| Thomas M. Ross Officer | Jun 20, 2024 | 133,332 | $587.99K | Jun 20, 2024 | Option Exercise |
| John Joseph Johnston Affiliate | Feb 26, 2024 | 10,000 | $45.90K | Feb 26, 2024 | option exercise |
| Douglas Doerfler Officer | Nov 29, 2023 | 150,000 | $702.00K | Nov 29, 2023 | Option Exercise |
| John Joseph Johnston Affiliate | Nov 14, 2023 | 20,000 | $74.20K | Nov 14, 2023 | option exercise |
| Douglas Doerfler Officer | Jul 10, 2023 | 90,000 | $416.70K | Jul 10, 2023 | Option Exercise |
| John Joseph Johnston Affiliate | Jun 26, 2023 | 25,000 | $117.00K | Jun 26, 2023 | option exercise |